Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation

WHAT IS CURRENTLY KNOWN ABOUT THIS TOPIC?: Familial hypercholesterolemia (FH) is characterized by elevated LDL-C levels. LDLR null mutations protected pancreatic β-cells from cholesterol accumulation. NGS has improved FH diagnosis by analysis of all genes implicated in the lipid disorder. WHAT IS THE KEY RESEARCH QUESTION?: What is the impact of FH genotype (monogenic with or without LDLR mutation/polygenic) on glycemic status? WHAT IS NEW?: FH population was characterized by a heterogeneous glycemic profile according to LDLR mutation. LDL-C and plasma glucose could modulate the distribution of subclinical atherosclerosis. HOW MIGHT THIS STUDYINFLUENCE CLINICAL PRACTICE?: Genetic, lipid, glucose data could better identify the metabolic and atherosclerotic profiles in FH.

Authors

Institutions

Publication Details

Journal
Cardiovascular Diabetology
Published
2025-03-20
DOI
https://doi.org/10.1186/s12933-025-02683-y
Citations
28
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
56.18
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation

Marco Musmeci, Nicoletta Miano, Francesco Purrello, Salvatore Piro et al.
28 citations
Cardiovascular Diabetology
Lipoproteins and Cardiovascular Health
56.18
article

Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation

Marco Musmeci, Nicoletta Miano, Francesco Purrello, Salvatore Piro, Sabrina Scilletta, Giosiana Bosco, L. Masana, Roberto Scicali, Maurizio Di Marco, Ana González-Lleó, Ernestina Marianna De Francesco, Daiana Ibarretxe, Antonino Di Pino, Roberta Malaguarnera, Francesco Barbagallo, Marina Martedì
article en
28 citations

Abstract

WHAT IS CURRENTLY KNOWN ABOUT THIS TOPIC?: Familial hypercholesterolemia (FH) is characterized by elevated LDL-C levels. LDLR null mutations protected pancreatic β-cells from cholesterol accumulation. NGS has improved FH diagnosis by analysis of all genes implicated in the lipid disorder. WHAT IS THE KEY RESEARCH QUESTION?: What is the impact of FH genotype (monogenic with or without LDLR mutation/polygenic) on glycemic status? WHAT IS NEW?: FH population was characterized by a heterogeneous glycemic profile according to LDLR mutation. LDL-C and plasma glucose could modulate the distribution of subclinical atherosclerosis. HOW MIGHT THIS STUDYINFLUENCE CLINICAL PRACTICE?: Genetic, lipid, glucose data could better identify the metabolic and atherosclerotic profiles in FH.

Cardiovascular DiabetologyVol. 24(1)
Università degli Studi di Enna Kore (IT), University of Catania (IT), Institut de Recerca Biomèdica Catalunya Sud (ES), Ospedale Garibaldi (IT), Hospital Universitari Sant Joan de Reus (ES)
Good health and well-being
Openalex Percentile: Top 0%
Lipoproteins and Cardiovascular Health
56.18
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.